Alan Xu
Chief Operating Officer at Ablaze Pharmaceuticals
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hong Zhong Liu | M | 59 |
Fudan University
| 34 years |
| Alex Qiao | M | - |
Ablaze Pharmaceuticals
 Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | 3 years |
| Pak Joe Chan | M | 71 |
Fudan University
| 19 years |
| Chang Jiang Lü | M | 59 |
Fudan University
| 18 years |
| Qiu Zhi Xue | M | 67 |
Fudan University
| 31 years |
| Bai Chun Xiao | M | 76 |
Fudan University
| 19 years |
| Zhong Ning | M | 60 |
Fudan University
| 18 years |
| Aaron Royston | M | 40 |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | - |
| Jin Zhong Chen | M | 59 |
Fudan University
| 18 years |
| Min Bo Li | M | 54 |
Fudan University
| 17 years |
| Ken Song | M | - |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | - |
| Hongbo Lu, PhD | - | - |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | - |
| Benjamin Qiu | M | - |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Li Chen | M | 58 |
Fudan University
| 11 years |
| Yi Sun | M | 52 |
Fudan University
| 10 years |
| Xiong Wen Lu | M | 58 |
Fudan University
| 5 years |
| Huai Zhang | M | 54 |
Fudan University
| 9 years |
| Ming Fang Lü | M | 67 |
Fudan University
| 6 years |
| Hong Wei Hua | M | 51 |
Fudan University
| 7 years |
| Shou Dong Wang | M | 46 |
Fudan University
| 7 years |
| Tian Cheng | M | 42 |
Fudan University
| 7 years |
| Chang Jian Jiang | M | 59 |
Fudan University
| 5 years |
| Jian Huang | M | 54 |
Fudan University
| 6 years |
| Feng Liu | M | 55 |
Fudan University
| 7 years |
| Ren Gu | M | 41 |
Fudan University
| 6 years |
| Feng Li | M | 48 |
Fudan University
| 6 years |
| Gu Jiefeng | M | 41 |
Fudan University
| 6 years |
| Zhi Hua Zhang | M | 43 |
Fudan University
| 4 years |
| Xiao Peng Guo | M | 41 |
Fudan University
| 7 years |
| Yang Xie | M | 54 |
Fudan University
| 6 years |
| Jing Ji | M | 54 |
Fudan University
| 6 years |
| Jiandong Ding | M | 59 |
Fudan University
| 5 years |
| Ming Tian | M | 55 |
Fudan University
| 8 years |
| Cindy Liu | F | - |
Fudan University
| 8 years |
| Hai Xiao Zhang | M | 53 |
Fudan University
| 22 years |
| Jin Ma | M | 38 |
Fudan University
| 7 years |
| Ming Xu | M | 41 |
Fudan University
| 6 years |
| Xiao Yi Ma | M | 50 |
Fudan University
| 2 years |
| Li Guang Chen | M | 45 |
Fudan University
| 6 years |
| Ping Gong | M | 49 |
Fudan University
| 6 years |
| Ming Yang Yu | M | 60 |
Fudan University
| 5 years |
| Jian Ming Chen | M | 69 |
Fudan University
| 6 years |
| Xin Yu Zhou | M | 55 |
Fudan University
| 6 years |
| Winston Ma | M | 50 |
Fudan University
| 6 years |
| Xiao Dong Zheng | M | 47 |
Fudan University
| 6 years |
| Da Jun Zhao | M | 54 |
Fudan University
| 6 years |
| Wilson Sea | M | 60 |
Fudan University
| 5 years |
| Xiao Chuan Guo | M | 58 |
Fudan University
| 4 years |
| Chang Jian Jiang | M | 58 |
Fudan University
| 6 years |
| Yong Xiang Jiang | M | 55 |
Fudan University
| 8 years |
| Xiao Bin Jin | M | 70 |
Fudan University
| 5 years |
| Cong Ming Fan | M | 45 |
Fudan University
| 1 years |
| Xian Lin Zhu | M | 63 |
Fudan University
| 3 years |
| Shu Min Zhu | M | 64 |
Fudan University
| 2 years |
| Hao Jiang | M | 47 |
Fudan University
| 4 years |
| Yi Fan He | F | 40 |
Fudan University
| 3 years |
| Yi Qun Chu | M | 41 |
Fudan University
| 4 years |
| Xiao Wang | M | 53 |
Fudan University
| 4 years |
| Yang Bin Huang | M | 52 |
Fudan University
| 4 years |
| Bing Chen | M | 50 |
Fudan University
| 4 years |
| Yi Xin | M | 45 |
Fudan University
| 3 years |
| Jun Lu | M | 50 |
Fudan University
| 4 years |
| Zhi Xiang Sun | F | 56 |
Fudan University
| 3 years |
| Xing Hua Li | M | 47 |
Fudan University
| 4 years |
| Jun Ren | M | 56 |
Fudan University
| 4 years |
| Ning Lin | M | - |
Fudan University
| 4 years |
| Gang Yao | M | 47 |
Fudan University
| 1 years |
| Xu Dong Chen | M | - |
Fudan University
| 4 years |
| Shao Qing Jiang | M | 50 |
Fudan University
| 4 years |
| Xin Hao Jiang | M | 59 |
Fudan University
| 3 years |
| Xin Chen | M | 49 |
Fudan University
| 4 years |
| Bang Yong Wang | M | 41 |
Fudan University
| 3 years |
| Chao Han | M | 35 |
Fudan University
| 4 years |
| Shi Zheng Qian | M | 72 |
Fudan University
| 3 years |
| Mao Xian Lin | M | 59 |
Fudan University
| 2 years |
| Zhi Ming Lu | M | - |
Fudan University
| 3 years |
| Yi Min Wang | M | 73 |
Fudan University
| 4 years |
| Zhen Li | M | 44 |
Fudan University
| 1 years |
| Yong Chang Qiang | M | 59 |
Fudan University
| 3 years |
| Jie Luo | M | - |
Fudan University
| 1 years |
| Chun Bao Yang | M | 54 |
Fudan University
| 3 years |
| Fei Chen | M | 44 |
Fudan University
| 3 years |
| Cai Yong Wang | M | 73 |
Fudan University
| 4 years |
| Duan Qing Lin | F | 47 |
Fudan University
| 4 years |
| Li Guo Wang | M | 55 |
Fudan University
| 4 years |
| Zhi Gang Xu | M | 64 |
Fudan University
| 2 years |
| Zhi Feng Zhou | M | 54 |
Fudan University
| 3 years |
| Shao Yan Li | F | 62 |
Fudan University
| 2 years |
| Zhi Jun Huang | M | 50 |
Fudan University
| 4 years |
| Tommy Tang. | M | - |
Fudan University
| 5 years |
| Xin Xu | M | 48 |
Fudan University
| 4 years |
| Ji Wan Qiu | M | 52 |
Fudan University
| 4 years |
| Sai Ma | M | 54 |
Fudan University
| 4 years |
| Xiao Guang Yang | M | 64 |
Fudan University
| 2 years |
| Guang Zhe Zhao | M | 49 |
Fudan University
| 4 years |
| Bin Liu | M | 50 |
Fudan University
| 3 years |
| Zhi Fang Wan | F | 46 |
Fudan University
| 4 years |
| Qiao Qi Zhou | M | 35 |
Fudan University
| 4 years |
| Wei Xu | M | 51 |
Fudan University
| 4 years |
| Cheng Cao | M | 50 |
Fudan University
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Xu
- Personal Network
